A Newborn with Gastric Hemangioma Treated Using Propranolol

KAYA H. , GÖKCE İ. K. , Gungor S. , TURGUT H. , ÖZDEMİR R.

PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, vol.21, no.4, pp.341-346, 2018 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.5223/pghn.2018.21.4.341
  • Page Numbers: pp.341-346


Gastric hemangiomas are rare benign vascular tumors that can cause severe gastrointestinal system bleeding. We presented the case of a neonate with fresh bleeding and melena from the orogastric tube and detected gastric hemangioma in esophagogastroduodenoscopic examination. Propranolol is widely used in treatment of cutaneous hemangiomas and non-gastric gastrointestinal system hemangiomas. However, the surgical approach is preferred for treating gastric hemangiomas, and there are few reports of gastric hemangiomas associated with non-surgical treatment. Gastric hemorrhage decreased with antacid and somatostatin treatment. Propranolol treatment was initiated before the surgery decision. After three weeks of treatment, we observed regression in the hemangioma with endoscopic evaluation. During the course of treatment, the patient's gastrointestinal system bleeding did not recur, and there were no side effects associated with propranolol.